Novel Drug Therapy in Stroke Treatment

Ali Alawieh, an M.D./Ph.D candidate at the Medical University of South Carolina (MUSC), discusses the findings of a May 16 Science Translational Medicine article he co-authored with Stephen Tomlinson, Ph.D., a professor in the Department of Microbiology and Immunology  and other researchers at MUSC about complement inhibition and stroke. In the article, they describe a novel drug therapy that could help prevent destruction of salvageable neurons after stroke and one day expand the treatments open to patients after stroke.

Read more about their findings in an article in Progressnotes, MUSC’s medical magazine.

Related Presenters

Stephen Tomlinson, PhD.

Stephen Tomlinson, PhD

The laboratory of Stephen Tomlinson, Ph.D., is focused on the biology of the complement system, and how it modulates an inflammatory response and shapes adaptive immunity. Within the context of complement-modulated immunity, areas of study ...

View full profile